- Category
- Micro (2024-25)
- Udyam number
- UDYAM-AP-17-0009193

Makdo Pharmaceuticals Private Limited
About Makdo Pharmaceuticals Private Limited
Data last updated:
Makdo Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the online healthcare product retail segment of the e-commerce sector. It was incorporated on 07 December 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U72900TG2022PTC168936. Its GSTIN is 37AAQCM4183P1ZI (Andhra Pradesh).
The company has an authorised share capital of ₹10,000 and a paid-up capital of ₹10,000. It is led by directors Naga Satish Kumar Kota and Ramya Pandi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8 – 2 – 630/B/B/1 Mount Banjara Road No 12 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2024, the company reported a revenue of ₹67.5 Lakh. For the same year it recorded a net profit of ₹800 (net margin 0%) and EBITDA of ₹1.97 Lakh (EBITDA margin 2.9%).
Makdo Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-17-0009193). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Makdo Pharmaceuticals
Contact details
Makdo Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered Address8 – 2 – 630/B/B/1 Mount Banjara Road No 12 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryE-Commerce, Online Healthcare Product Retail
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Makdo Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Makdo Pharmaceuticals Private Limited, buy the company report.
Financials of Makdo Pharmaceuticals Private Limited
FY 2025 filings availableMakdo Pharmaceuticals Private Limited reported revenue of ₹67.5 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹1.97 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹800 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.9% | |
| Net Profit Margin | 0% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Makdo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Makdo Pharmaceuticals Private Limited
Makdo Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naga Satish Kumar Kota | Director | 07 Dec 2022 | 3 Years 10 Months | Current |
| Ramya Pandi | Director | 07 Dec 2022 | 3 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Makdo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Makdo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Makdo Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAQCM4183P1ZI | Andhra Pradesh | Active | 14 Feb 2023 |
To see the full GST registrations and return filing status of Makdo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Makdo Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Naga Satish Kumar Kota was appointed as Director on 07 Dec 2022.
Frequently asked questions
Makdo Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in online healthcare product retail, within the e-commerce industry. It was incorporated on 07 December 2022 (4+ years old) and is registered under CIN U72900TG2022PTC168936.
Makdo Pharmaceuticals has 2 current directors:
- Naga Satish Kumar Kota - Director
- Ramya Pandi - Director
The latest financial statements of Makdo Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Makdo Pharmaceuticals is 37AAQCM4183P1ZI, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Makdo Pharmaceuticals is U72900TG2022PTC168936. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Makdo Pharmaceuticals was incorporated on 07 December 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
Naga Satish Kumar Kota was appointed as Director on 07 Dec 2022. Ramya Pandi was appointed as Director on 07 Dec 2022.
Yes, Makdo Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-17-0009193).
The registered office of Makdo Pharmaceuticals is at 8 – 2 – 630BB1 Mount Banjara Road No 12 Banjara Hills, Hyderabad, Telangana, India – 500034.
Makdo Pharmaceuticals operates in the e-commerce industry, in the online healthcare product retail segment.

